Results 121 to 130 of about 1,354 (149)
Some of the next articles are maybe not open access.
Brimonidine Tartrate Poisoning in Children: Frequency, Trends, and Use of Naloxone as an Antidote
Pediatrics, 2009BACKGROUND. Brimonidine tartrate, a centrally acting selective α-2 adrenergic agonist with a toxicity that is often compared with that of clonidine, is used as eye drops to lower intraocular pressure in glaucoma. We investigated characteristics of childhood exposures to brimonidine-containing products. METHODS.
Melisa, Lai Becker +2 more
openaire +2 more sources
The effect of brimonidine tartrate on retinal blood flow in patients with ocular hypertension
American Journal of Ophthalmology, 2000To study the effects of topical brimonidine tartrate 0.2%, an alpha(2)-agonist ocular hypotensive drug, on retinal capillary blood flow in patients with ocular hypertension.The study was a double-masked, randomized, placebo-controlled trial set in a tertiary eye center.
A M, Carlsson +3 more
openaire +2 more sources
In vitro characterization of a controlled-release ocular insert for delivery of brimonidine tartrate
Acta Biomaterialia, 2014Glaucoma is the second leading cause of blindness in the US. Brimonidine tartrate (BT) is a modern anti-glaucoma agent that is currently administered as frequently as a thrice-daily topical eye drop medication. Accordingly, compliance with BT regimens is low, limiting overall effectiveness. One attempt that has previously proved effective in addressing
J E, Mealy, M V, Fedorchak, S R, Little
openaire +2 more sources
The effect of daily use of brimonidine tartrate on the dark-adapted pupil diameter
American Journal of Ophthalmology, 2004To investigate the effect of daily brimonidine tartrate 0.15% on the dark-adapted pupil diameter.Observational case series.Ten normal volunteers administered brimonidine to their right eyes once daily. Four to six hours later, infrared pupil photographs were taken after dark adaptation.
Sandra M, Brown +2 more
openaire +2 more sources
Sedative and physiological effects of brimonidine tartrate ophthalmic solution in healthy cats
Veterinary Anaesthesia and Analgesia, 2017To determine the effects of brimonidine tartrate ophthalmic solution on sedation, heart rate (HR), respiratory frequency (fR), rectal temperature (RT) and noninvasive mean arterial pressure (MAP) in healthy cats.Randomized, blinded crossover study, with 1 week washout between treatments.Six healthy purpose-bred cats.Brimonidine tartrate ophthalmic ...
Niwako, Ogata +8 more
openaire +2 more sources
Charles Bonnet Syndrome Precipitated by Brimonidine Tartrate
Journal of Medical OptometryCharles Bonnet Syndrome (CBS) induced by brimonidine tartrate ophthalmic solution has rarely been reported. CBS is a condition characterized by visual hallucinations in patients with vision loss and clear cognition. This condition is more prevalent in the elderly population, between the ages of 75 and 84 years old.
openaire +1 more source
Brimonidine tartrate: a one-month dose response study.
Ophthalmology, 1997Brimonidine tartrate is a relatively selective alpha2-agonist that effectively reduces mean intraocular pressure (IOP) and the incidence of IOP spikes after laser trabeculoplasty. The authors were interested in evaluating the dose response of brimonidine when applied topically for a longer duration in patients with elevated IOPs.The authors conducted a
R J, Derick +8 more
openaire +1 more source